a clinical follow-up study of premature thelarche in infants under the age of two

1
POSTER PRESENTATION Open Access A clinical follow-up study of premature thelarche in infants under the age of two Yingmin Wang * , Li Liang, Yanlan Fang, Junfen Fu, Guanping Dong, Chunlin Wang From 7th APPES Biennial Scientific Meeting Nusa Dua, Bali. 14-17 November 2012 Objective Assess the clinical status and natural course of premature thelarche in infants under the age of 2 years as well as ana- lyze the predictive factors for thelarche regression. Method Through Hospital Information System, analyze the hospital-based prevalence of premature thelarche in infants under the age of 2 years in recent 3 years as well as analyze the follow-up databases of clinical features and laboratory data in 890 patients under 2 years old from October 2009 to September 2010. Result 1.Hospital-based prevalence in infants under the age of 2 years in 2009, 2010 and 2011 is 0.26, 0.40, 0.39relatively. On average it s 0.35. Period from July to September in every year is the peak time of doctor visiting. 2. Most (99.8%)of infants with premature thelarche are manifested as isolated premature thelarche, while only 0.2% are represented as peripheral precocious puberty. 3. Among the patients under the age of 2 years with isolated premature thelarche 89.5% of them get a regression between the age of 2 and 3 years( The average of regres- sion age is 17±5.8 months), 10.5% of them do not make recovery by the age of 3 years and even some (0.4%) turn into central precocious puberty(CPP). 4. The two influen- cing factors of breast regression are breast size by the first time of doctor visiting and whether basal estrogen is high or not. Conclusion Premature thelarche in infants under the age of 2 is not a rare disease. Remaining of premature thelarche is probably associated with minipuberty and environmental estrogen disruptors. Premature thelarche in the majority manifested as a self-limited condition. Meanwhile, follow- ups at regular intervals to those remaining symptoms above 2 years old are needed. Published: 3 October 2013 doi:10.1186/1687-9856-2013-S1-P129 Cite this article as: Wang et al.: A clinical follow-up study of premature thelarche in infants under the age of two. International Journal of Pediatric Endocrinology 2013 2013(Suppl 1):P129. Submit your next manuscript to BioMed Central and take full advantage of: Convenient online submission Thorough peer review No space constraints or color figure charges Immediate publication on acceptance Inclusion in PubMed, CAS, Scopus and Google Scholar Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit Department of Endocrinology, Childrens Hospital Affiliated to Zhejiang University Medicale College, Hangzhou 310003, China Wang et al. International Journal of Pediatric Endocrinology 2013, 2013(Suppl 1):P129 http://www.ijpeonline.com/content/2013/S1/P129 © 2013 Wang et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Upload: chunlin

Post on 23-Dec-2016

215 views

Category:

Documents


2 download

TRANSCRIPT

POSTER PRESENTATION Open Access

A clinical follow-up study of premature thelarchein infants under the age of twoYingmin Wang*, Li Liang, Yanlan Fang, Junfen Fu, Guanping Dong, Chunlin Wang

From 7th APPES Biennial Scientific MeetingNusa Dua, Bali. 14-17 November 2012

ObjectiveAssess the clinical status and natural course of prematurethelarche in infants under the age of 2 years as well as ana-lyze the predictive factors for thelarche regression.

MethodThrough Hospital Information System, analyze thehospital-based prevalence of premature thelarche ininfants under the age of 2 years in recent 3 years as wellas analyze the follow-up databases of clinical featuresand laboratory data in 890 patients under 2 years oldfrom October 2009 to September 2010.

Result1.Hospital-based prevalence in infants under the age of2 years in 2009, 2010 and 2011 is 0.26‰, 0.40‰, 0.39‰relatively. On average it’s 0.35‰. Period from July toSeptember in every year is the peak time of doctor visiting.2. Most (99.8%)of infants with premature thelarche aremanifested as isolated premature thelarche, while only0.2% are represented as peripheral precocious puberty. 3.Among the patients under the age of 2 years with isolatedpremature thelarche 89.5% of them get a regressionbetween the age of 2 and 3 years( The average of regres-sion age is 17±5.8 months), 10.5% of them do not makerecovery by the age of 3 years and even some (0.4%) turninto central precocious puberty(CPP). 4. The two influen-cing factors of breast regression are breast size by the firsttime of doctor visiting and whether basal estrogen is highor not.

ConclusionPremature thelarche in infants under the age of 2 is nota rare disease. Remaining of premature thelarche isprobably associated with minipuberty and environmental

estrogen disruptors. Premature thelarche in the majoritymanifested as a self-limited condition. Meanwhile, follow-ups at regular intervals to those remaining symptomsabove 2 years old are needed.

Published: 3 October 2013

doi:10.1186/1687-9856-2013-S1-P129Cite this article as: Wang et al.: A clinical follow-up study of prematurethelarche in infants under the age of two. International Journal ofPediatric Endocrinology 2013 2013(Suppl 1):P129.

Submit your next manuscript to BioMed Centraland take full advantage of:

• Convenient online submission

• Thorough peer review

• No space constraints or color figure charges

• Immediate publication on acceptance

• Inclusion in PubMed, CAS, Scopus and Google Scholar

• Research which is freely available for redistribution

Submit your manuscript at www.biomedcentral.com/submitDepartment of Endocrinology, Children’s Hospital Affiliated to Zhejiang

University Medicale College, Hangzhou 310003, China

Wang et al. International Journal of Pediatric Endocrinology 2013, 2013(Suppl 1):P129http://www.ijpeonline.com/content/2013/S1/P129

© 2013 Wang et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative CommonsAttribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction inany medium, provided the original work is properly cited.